This study aims to assess the effectiveness and morbidity of water vapor thermal therapy (Rezūm therapy) for benign prostatic hyperplasia (BPH). Data will be collected and analyzed from patients treated by Rezūm and followed up for 4 years prior to evaluating clinical outcomes.

The investigators will conduct a retrospective study evaluating patients treated with water vapor thermal therapy (Rezūm therapy) for BPH and followed up for4 years. The primary objectives are to assess the long-term effectiveness and morbidity rates associated with the procedure. Data collected will include urinary symptom scores, sexual function, and any treatment-related complications.

Inclusion Criteria:

• patients underwent rezum procedure for benign prostatic hyperplasia from 2 to 4 years

Exclusion Criteria:

• previous prostatic intervention
• concurrent urological morbidity like urethral stricture
• neurological disease like parkinson's disease

the disease is conclusive for men

Patients are not permitted to post any of their personal information